fda warning letters glp-1 compounding september 26 2025 Compounded" drugs | Health Communication Research Laboratory FDA issued 25 warning letters

It just shows you the level of desperation that people have and the level of unmet need that we have when it comes to treating obesity effectively."

FIBO is rare, but it can become very severe once it happens

The mitochondria exhibited cristae loss, membrane rupture, and mitochondrial swelling, which was observed with an increase in ATP abundance, complex I activity, and deficiency in the activities of complexes II and IV

Understanding your individual biomarkers and genetic predispositions can help guide safer, more personalized weight loss decisions with your p

PlexusDx explains practical post-injection hygiene guidelines to optimize your treatment experience

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits